Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Michael Abrams, MA

Advertisement

Articles by Michael Abrams, MA

The Emergence of the Chief Value Officer in Healthcare

ByMichael Abrams, MA
June 9th 2022

Outlining the implications of this c-suite trend for pharma.

Time for Pharma to Reimagine the Medical Affairs Role

ByMichael Abrams, MA
June 9th 2021

Commercial-model shift demanding greater influence of these teams.

Advertisement

Latest Updated Articles

  • Time for Pharma  to Reimagine the  Medical Affairs Role
    Time for Pharma to Reimagine the Medical Affairs Role

    June 9th 2021



Advertisement
Advertisement

Trending on PharmExec

1

From Value Imperative to Operating Reality: Rethinking Trust in Pharma

2

Pharma’s New Growth Equation: Smarter Deals, Stronger Science, Rising Costs

3

2026 Pharm Exec Top 50 Companies

4

Everything You Need to Know About the AstraZeneca–Bristol Myers Squibb Merger Rumors

5

FDA Grants Accelerated Approval to Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Multiple Myeloma

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us